Drug-induced bone loss: a major safety concern in Europe

Expert Opinion on Drug Safety
Khac-Dung NguyenHaleh Bagheri

Abstract

Drug-induced bone loss remains the major cause of vertebral and hip fractures and significantly associated to morbidity and mortality. This article will review the common drugs identified as the causes of bone loss and the risk factors and management in European countries. Beyond glucorticoid - the most cause of osteoporosis, many different drugs could cause harmful skeletal disorders. The antiepileptics, hormonal therapy, GnRH antagonists, aromatase inhibitors are well-known cause of bone loss. Osteoporosis and fractures risk also increased with calcineurin inhibitors, antiretroviral drugs, selective inhibitors of serotonin reuptake, loop diuretics, heparins, oral anticoagulants, high doses of thyroxine and proton pump inhibitors. Drugs are an important secondary cause of osteoporosis. Healthcare professionals should reassess the requirement for drugs and use the lowest dosage and shortest duration. Lifestyle changes, adequate calcium, vitamin D supplement, appropriate monitoring of bone status and initiating osteoporosis treatment if indicated are recommended when drugs having potential deleterious effects on bone are used, particularly in high risk patients. The update and further studies would provide concluded evidences of...Continue Reading

References

Jul 4, 1992·Lancet·J A FranklynM C Sheppard
Mar 1, 1991·The American Journal of Medicine·E V AdlinB J Channick
Aug 15, 1990·Annals of Internal Medicine·G M StallB Dawson-Hughes
Jun 3, 1988·JAMA : the Journal of the American Medical Association·T L PaulD T Baran
Mar 23, 1995·The New England Journal of Medicine·S R CummingsT M Vogt
Jan 1, 1994·Annals of Internal Medicine·T DiamondP Butler
May 14, 1998·Clinical Endocrinology·F W HannaJ H Lazarus
May 29, 1999·Acta Neurologica Scandinavica·P VestergaardL Mosekilde
Aug 17, 1999·Archives of Internal Medicine·P J CaraballoL J Melton
Nov 30, 2000·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P Tannirandorn, S Epstein
Sep 29, 2001·The New England Journal of Medicine·M R SmithJ S Finkelstein
Feb 28, 2002·Archives of Internal Medicine·Michael C SheppardJayne A Franklyn
May 15, 2002·Mayo Clinic Proceedings·Lorraine A Fitzpatrick
May 16, 2002·Current Rheumatology Reports·Kenneth G Saag
May 22, 2002·Archives of Neurology·Dennis L AndressWilliam Spain
Jun 11, 2002·Annual Review of Nutrition·John L OmdahlBrian K May
Jul 10, 2002·Epilepsia·Hakan B I PerssonT Tomson
Aug 6, 2002·The Journal of Clinical Endocrinology and Metabolism·Daniella MittanJan M Bruder
Oct 16, 2002·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·T P van StaaC Cooper
Apr 2, 2003·Expert Opinion on Pharmacotherapy·Jean-Jacques Body
Apr 30, 2003·Archives of Internal Medicine·Kristine E EnsrudUNKNOWN Study of Osteoporotic Fractures Research Group
Jun 14, 2003·Annals of Internal Medicine·D C BauerUNKNOWN Study of Osteoporotic Fractures Research Group
Jul 2, 2003·American Journal of Epidemiology·Richard HubbardAnne Tattersfield
Feb 6, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Michael SteinbuchStanley Cohen
May 5, 2004·Epilepsy & Behavior : E&B·Marc K Drezner
Jan 14, 2005·The New England Journal of Medicine·Vahakn B ShahinianJames S Goodwin
Mar 15, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kristin MondyPablo Tebas
Sep 9, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·T P Van StaaC Cooper
Oct 13, 2005·Acta Neurologica Scandinavica·P Vestergaard
Dec 13, 2005·Journal of Internal Medicine·L RejnmarkL Mosekilde
Dec 16, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Lars RejnmarkLeif Mosekilde
May 4, 2006·Clinical Rheumatology·Margaret GourlayYevgeniy Sheyn
Jun 23, 2006·Journal of Internal Medicine·P VestergaardL Mosekilde
Jul 22, 2006·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Barbara A CromerUNKNOWN Society for Adolescent Medicine
Aug 12, 2006·Journal of Child Neurology·Hasan TekgulSarenur Gökben

❮ Previous
Next ❯

Citations

Feb 9, 2019·Expert Review of Endocrinology & Metabolism·Luciano ColangeloSalvatore Minisola
Aug 31, 2019·European Journal of Clinical Pharmacology·Quentin DardonvilleHaleh Bagheri
Jan 29, 2020·Pharmacoepidemiology and Drug Safety·Luca PasinaAladar Ianes
Feb 12, 2019·Drugs & Aging·L J SeppalaUNKNOWN EuGMS Special Interest Group on Pharmacology
Jun 7, 2020·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J E M SaleL Funnell
Dec 20, 2020·Pediatric Transplantation·Kirstin KusumiJohn D Mahan
Apr 13, 2021·International Journal of Cancer. Journal International Du Cancer·Daria Maria FilippiniLisa Licitra
Mar 26, 2020·Current Diabetes Reviews·Moein AlaAhmad Reza Dehpour
Jun 19, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lingyun LuXijie Yu
Sep 29, 2021·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Joanna E M SaleLarry Funnell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

La Revue du praticien
Karine Briot
The American Journal of Medicine
Gherardo MazziottiAndrea Giustina
Climacteric : the Journal of the International Menopause Society
D V ByreddyE M Lewiecki
Cleveland Clinic Journal of Medicine
Faye N Hant, Marcy B Bolster
© 2022 Meta ULC. All rights reserved